Number of studies: k = 12
Number of treatments: n = 9
Number of pairwise comparisons: m = 12
Number of designs: d = 8

Fixed effects model

Treatment estimate (sm = 'OR'):
             daridorexant doxepin eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem
daridorexant            .  0.5544      0.3869      0.3432    0.2013  0.5474    0.7003     0.9250   0.2829
doxepin            1.8036       .      0.6978      0.6189    0.3630  0.9873    1.2630     1.6684   0.5102
eszopiclone        2.5849  1.4332           .      0.8870    0.5203  1.4150    1.8101     2.3911   0.7312
lemborexant        2.9141  1.6157      1.1273           .    0.5865  1.5952    2.0406     2.6955   0.8244
melatonin          4.9684  2.7547      1.9221      1.7050         .  2.7198    3.4792     4.5958   1.4055
placebo            1.8268  1.0128      0.7067      0.6269    0.3677       .    1.2792     1.6898   0.5168
ramelteon          1.4280  0.7918      0.5525      0.4901    0.2874  0.7817         .     1.3209   0.4040
suvorexant         1.0811  0.5994      0.4182      0.3710    0.2176  0.5918    0.7570          .   0.3058
zolpidem           3.5349  1.9599      1.3675      1.2131    0.7115  1.9351    2.4754     3.2698        .

Lower 95%-confidence limit:
             daridorexant doxepin eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem
daridorexant            .  0.0916      0.1637      0.1129    0.0693  0.2549    0.2071     0.3475   0.1095
doxepin            0.2979       .      0.1304      0.1003    0.0605  0.1933    0.1915     0.2924   0.0909
eszopiclone        1.0938  0.2678           .      0.3611    0.2243  0.9541    0.6480     1.1548   0.3679
lemborexant        0.9585  0.2619      0.4590           .    0.1957  0.7114    0.5871     0.9786   0.3081
melatonin          1.7108  0.4590      0.8288      0.5690         .  1.2936    1.0427     1.7551   0.5534
placebo            0.8505  0.1983      0.4765      0.2796    0.1749       .    0.4954     0.9164   0.2944
ramelteon          0.4223  0.1200      0.1978      0.1410    0.0861  0.3028         .     0.4272   0.1341
suvorexant         0.4061  0.1050      0.2020      0.1347    0.0831  0.3210    0.2448          .   0.1332
zolpidem           1.3682  0.3492      0.6880      0.4533    0.2801  1.1024    0.8216     1.4240        .

Upper 95%-confidence limit:
             daridorexant doxepin eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem
daridorexant            .  3.3571      0.9143      1.0433    0.5845  1.1757    2.3678     2.4625   0.7309
doxepin           10.9211       .      3.7347      3.8185    2.1786  5.0423    8.3307     9.5207   2.8636
eszopiclone        6.1089  7.6710           .      2.1787    1.2066  2.0986    5.0561     4.9509   1.4535
lemborexant        8.8598  9.9678      2.7689           .    1.7575  3.5771    7.0924     7.4244   2.2059
melatonin         14.4286 16.5312      4.4576      5.1090         .  5.7184   11.6094    12.0344   3.5699
placebo            3.9235  5.1724      1.0481      1.4057    0.7730       .    3.3030     3.1157   0.9071
ramelteon          4.8287  5.2223      1.5432      1.7032    0.9591  2.0185         .     4.0843   1.2172
suvorexant         2.8781  3.4205      0.8660      1.0218    0.5698  1.0912    2.3407          .   0.7023
zolpidem           9.1330 10.9995      2.7183      3.2459    1.8071  3.3968    7.4582     7.5084        .

Random effects model

Treatment estimate (sm = 'OR'):
             daridorexant doxepin eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem
daridorexant            .  0.5546      0.3868      0.3433    0.2013  0.5476    0.7005     0.9256   0.2828
doxepin            1.8030       .      0.6974      0.6189    0.3630  0.9873    1.2630     1.6689   0.5099
eszopiclone        2.5854  1.4340           .      0.8876    0.5206  1.4158    1.8112     2.3932   0.7312
lemborexant        2.9130  1.6157      1.1267           .    0.5865  1.5952    2.0406     2.6964   0.8239
melatonin          4.9665  2.7547      1.9210      1.7050         .  2.7198    3.4792     4.5972   1.4047
placebo            1.8261  1.0128      0.7063      0.6269    0.3677       .    1.2792     1.6903   0.5165
ramelteon          1.4275  0.7918      0.5521      0.4901    0.2874  0.7817         .     1.3214   0.4037
suvorexant         1.0803  0.5992      0.4179      0.3709    0.2175  0.5916    0.7568          .   0.3055
zolpidem           3.5358  1.9611      1.3676      1.2138    0.7119  1.9363    2.4769     3.2728        .

Lower 95%-confidence limit:
             daridorexant doxepin eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem
daridorexant            .  0.0914      0.1630      0.1124    0.0690  0.2544    0.2064     0.3465   0.1090
doxepin            0.2970       .      0.1299      0.1000    0.0603  0.1930    0.1909     0.2917   0.0906
eszopiclone        1.0899  0.2672           .      0.3596    0.2233  0.9511    0.6457     1.1512   0.3657
lemborexant        0.9541  0.2611      0.4565           .    0.1947  0.7088    0.5844     0.9748   0.3062
melatonin          1.7027  0.4575      0.8240      0.5660         .  1.2886    1.0377     1.7477   0.5497
placebo            0.8482  0.1980      0.4745      0.2786    0.1742       .    0.4939     0.9145   0.2928
ramelteon          0.4206  0.1197      0.1968      0.1403    0.0857  0.3018         .     0.4257   0.1333
suvorexant         0.4045  0.1047      0.2010      0.1341    0.0827  0.3201    0.2438          .   0.1324
zolpidem           1.3621  0.3483      0.6839      0.4511    0.2786  1.0978    0.8179     1.4182        .

Upper 95%-confidence limit:
             daridorexant doxepin eszopiclone lemborexant melatonin placebo ramelteon suvorexant zolpidem
daridorexant            .  3.3671      0.9175      1.0481    0.5873  1.1789    2.3778     2.4724   0.7342
doxepin           10.9453       .      3.7423      3.8307    2.1856  5.0512    8.3562     9.5474   2.8711
eszopiclone        6.1332  7.6953           .      2.1906    1.2135  2.1076    5.0805     4.9752   1.4623
lemborexant        8.8937  9.9994      2.7808           .    1.7668  3.5899    7.1253     7.4586   2.2170
melatonin         14.4864 16.5845      4.4780      5.1359         .  5.7406   11.6651    12.0925   3.5891
placebo            3.9311  5.1816      1.0514      1.4107    0.7761       .    3.3130     3.1241   0.9109
ramelteon          4.8454  5.2383      1.5488      1.7111    0.9637  2.0246         .     4.1013   1.2226
suvorexant         2.8856  3.4279      0.8687      1.0259    0.5722  1.0935    2.3490          .   0.7051
zolpidem           9.1782 11.0419      2.7349      3.2664    1.8191  3.4152    7.5006     7.5528        .

Quantifying heterogeneity / inconsistency:
tau^2 = 0.0015; tau = 0.0388; I^2 = 0.8% [0.0%; 79.4%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                   Q d.f. p-value
Total           4.03    4  0.4018
Within designs  4.03    4  0.4018
Between designs 0.00    0      --
[1] "A total of 9 treatments are included in the network."
[1] "A total of 12 studies are included in this analysis."
[1] "A total of 7953 participants are included in this analysis, with 408 events (5.13%)."
[1] "The following studies were included in this analysis: 45 46 58 59 60 75 112 130 136 155 159 160"
[1] "Estimated heterogeneity tau-squared0"
[1] "Global test for inconsistency, p-value NA (Q=0, d.o.f. 0)"
[1] "File created on 2022-01-25"
